In this editorial, we argue for a holistic view of evidence-based practices via the synergy of human and artificial intelligence in drug discovery. This strategy may build a collaborative conceptual framework to enable better-informed and rapid decisions, and the level of knowledge structuring can be adapted to meet the needs of the process. Thus, data integration will be shaped to highly contextualized and interrelated knowledge outputs.
Expert Opin Drug Discov. 2018 Sep;13(9):791-794. doi: 10.1080/17460441.2018.1504767. Epub 2018 Jul 30.